Novo Nordisk Says Investor Suit Pleadings Are Impermissible
Novo Nordisk AS urged a New Jersey federal court to toss a proposed securities class action accusing it of misleading investors about its 2025 revenue outlook, arguing that the plaintiffs failed...To view the full article, register now.
Already a subscriber? Click here to view full article